Healthcare & Life Sciences
Prophylix Pharma AS
Norway
About
Prophylix Pharma AS develops a prophylactic treatment targeting Neonatal Abstinence Syndrome (NAS), a medical condition affecting newborns.
Explore Prophylix Pharma AS's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.